Concourse Financial Group Securities’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,035
Closed -$20.4K 371
2024
Q4
$20.4K Hold
1,035
﹤0.01% 1542
2024
Q3
$19.2K Sell
1,035
-75
-7% -$1.51K ﹤0.01% 1525
2024
Q2
$22.5K Sell
1,110
-23
-2% -$407 ﹤0.01% 1480
2024
Q1
$19.4K Hold
1,133
﹤0.01% 1515
2023
Q4
$20K Hold
1,133
﹤0.01% 1486
2023
Q3
$27.2K Sell
1,133
-3,489
-75% -$85.6K ﹤0.01% 1337
2023
Q2
$107K Sell
4,622
-1,257
-21% -$28.4K 0.01% 856
2023
Q1
$130K Sell
5,879
-856
-13% -$20K 0.01% 793
2022
Q4
$137K Buy
+6,735
New +$131K 0.01% 733
2022
Q3
Sell
-6,913
Closed -$116K 2103
2022
Q2
$137K Buy
6,913
+349
+5% +$9.27K 0.01% 709
2022
Q1
$208K Buy
6,564
+2,736
+71% +$76.7K 0.02% 624
2021
Q4
$85K Sell
3,828
-735
-16% -$19.2K ﹤0.01% 1074
2021
Q3
$127K Buy
4,563
+906
+25% +$27.6K 0.01% 886
2021
Q2
$142K Buy
3,657
+1,689
+86% +$60.5K 0.01% 837
2021
Q1
$57K Buy
1,968
+15
+0.8% +$512 ﹤0.01% 1171
2020
Q4
$52K Buy
1,953
+453
+30% +$9.25K ﹤0.01% 1138
2020
Q3
$23K Buy
1,500
+1,033
+221% +$21.7K ﹤0.01% 1315
2020
Q2
$9K Buy
467
+456
+4,145% +$8.17K ﹤0.01% 1515
2020
Q1
$0 Sell
11
-58
-84% -$1.62K ﹤0.01% 2178
2019
Q4
$3K Sell
69
-23
-25% -$1.03K ﹤0.01% 1750
2019
Q3
$4K Sell
92
-29
-24% -$1.35K ﹤0.01% 1359
2019
Q2
$6K Hold
121
﹤0.01% 1647
2019
Q1
$8K Sell
121
-59
-33% -$3.96K ﹤0.01% 1578
2018
Q4
$10K Sell
180
-11
-6% -$949 ﹤0.01% 1421
2018
Q3
$22K Buy
+191
New +$21.5K 0.01% 821

Other funds holding CLB

Concourse Financial Group Securities's CLB Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 1,035 shares — an estimated $20.4K sold.

Concourse Financial Group Securities first reported a position in CLB in Q3 2018 and held it in 25 quarters. The position peaked at $208K in Q1 2022. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,035 Core Laboratories shares in Q1 2025, an estimated $20.4K.
  • Concourse Financial Group Securities first reported a position in Core Laboratories in Q3 2018 and held it in 25 quarters.
  • Concourse Financial Group Securities's Core Laboratories position peaked at $208K in Q1 2022.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.